Skip to content
The 11th International IP Index was published by the U.S. Chamber of Commerce, highlighting the danger of COVID-19 IP infringement and its potential impact […]
U.S. Chamber’s IP Index highlights progress and new threats Read More »
Acceligen has developed a breed of pigs resistant to the devastating disease Porcine Reproductive and Respiratory Syndrome (PRRS), the Biotechnology Innovation Organization (BIO) member
Acceligen develops new breed of pigs resistant to PRRS Read More »
The Pfizer RSV vaccine candidate for adults over 60 has been recommended by an advisory committee of the Food and Drug Administration (FDA), and
FDA panel recommends Pfizer RSV vaccine for older adults Read More »
Pain is the number one reason most Americans go to the doctor is pain, says Cindy Steinberg, Director of Policy and Advocacy for the
Can biotech crack the code on pain medications? Read More »
A significant increase in the percentage of Shigella infections caused by extensively drug-resistant (XDR) versions of the bacteria has prompted the U.S. Centers for
The rise of drug-resistant Shigella offers glimpse into danger AMR poses Read More »
The U.S. Department of Agriculture (USDA) held the 99th Agricultural Outlook Forum last week, where many speakers highlighted the potential of biotechnology and bio-based products.
USDA Agricultural Outlook Forum: SAF, carbon markets, and the future of biotechnology Read More »
According to a recent report from IQVIA, the market for biosimilars, which mimic innovative biologics, is poised to grow this year. Since 2007, a
Biosimilars expected to boom in 2023-27, says report Read More »
Starting Veklury (remdesivir) within the first two days of hospitalization for COVID-19 can reduce mortality and decrease readmission rates for all hospitalized patients, regardless
Gilead’s anti-COVID Veklury reduces risk of death Read More »
Pfizer’s vaccine aimed at protecting infants against severe respiratory syncytial virus (RSV) could roll out as early as this summer as the Food and
Pfizer’s RSV vaccine for infants could be approved this summer Read More »
Biotechnology Innovation Organization (BIO) member Acceligen partnered with the USDA’s Agricultural Research Service to develop gene-edited cattle resistant to bovine viral diarrhea (BVD), a
Acceligen’s gene-edited calf less susceptible to BVDV Read More »
